Centene Corp., US15133V1035

Centene steady in Medicaid space, shares track S&P 500 health peers

Published on 06/27/2026 at 10:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centene sits in the managed-care middle field as investors weigh Medicaid redeterminations, Medicare Advantage mix and valuation versus UnitedHealth and Elevance, with consensus pointing to moderate earnings growth.

Centene Corp., US15133V1035, Illustration mit AI erstellt.
Centene Corp., US15133V1035, Illustration mit AI erstellt.

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-27, 10:00.

Centene Corp. (US15133V1035) enters the end of the week as a mid-cap managed-care player on the New York Stock Exchange. The stock sits in the S&P 500 health care cohort alongside larger peers such as UnitedHealth Group and Elevance Health, which form the reference frame for many investors.

How Centene compares with peers

On the NYSE, Centene trades as a focused government-sponsored health insurer, while UnitedHealth and Elevance combine commercial, Medicare Advantage and services businesses at a larger scale. Analysts often group these names when assessing managed-care exposure in U.S. health care.

Market commentary from platforms such as MarketBeat describes Centene as a value-oriented managed-care name with sensitivity to Medicaid policy and redetermination trends rather than a broad health-services conglomerate like UnitedHealth or CVS Health.Recent Centene-focused news and analysis on MarketBeat

Sector focus on Medicaid and Medicare

Within the S&P 500 health care sector, Centene stands out for its concentration in Medicaid managed care and Affordable Care Act exchange plans. That distinguishes it from UnitedHealth, Elevance, CVS Health and Cigna, which have more diversified earnings streams across commercial insurance, Medicare Advantage and pharmacy benefits.

Investor discussions in recent months have centered on state-level Medicaid redeterminations and the evolution of Medicare Advantage margins, two themes that affect Centene’s revenue visibility and capital allocation in a different way than more diversified peers.Centene key figures and peer comparison on Yahoo Finance

Go deeper

Background and price data on Centene

All current news, data points and SEC disclosures on the Centene shares are compiled in the dedicated topic section.

The business behind Centene

Centene generates most of its revenue by administering Medicaid managed-care contracts for U.S. states, operating Medicaid plans for low-income individuals and families. It also offers Affordable Care Act marketplace coverage and Medicare Advantage products, adding to its government-focused portfolio.

Where the stock trades

The Centene shares (US15133V1035) trade on the NYSE under the ticker CNC; at the last available close on 2026-06-26 at 21:59 CET they were quoted at 65.69 US dollars.

Key data on the Centene shares

  • Company: Centene Corp.
  • ISIN: US15133V1035
  • WKN: 766458
  • Ticker: CNC
  • Trading venue: NYSE
  • Price (as of 2026-06-26, 21:59): 65.69 USD
  • Market cap: around 34 billion USD (as of June 2026)
  • Sector / industry: Health Care, Managed Care
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on the Centene shares in social media

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any financial instrument.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US15133V1035 | CENTENE CORP. | boerse | 69638231 | bgmi